Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Ramo Tello C. Precaucions en l'ús dels fàrmacs per a l'esclerosi múltiple. Butlletí d'Informació Terapèutica 2012;23:40-7. [Ref.ID 93279]
2.Tiene citas relacionadas Cita con resumen
King Jr TE, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM, for the INSPIRE Study Group. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 2009;374:222-8. [Ref.ID 86322]
3.Tiene citas relacionadas
Bouros D. Interferon gamma for idiopathic pulmonary fibrosis. Lancet 2009;374:180-2. [Ref.ID 86317]
5. Cita con resumen
Charles C, Clements P, Furst DE. Systemic sclerosis: hypothesis-driven treatment strategies. Lancet 2006;367:1683-91. [Ref.ID 77040]
6.
Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005;352:1899-912. [Ref.ID 73671]
7. Cita con resumen
Raghu G, Brown KK, Bradford WZ, Starko K, Noble P W, Schwartz DA, King TE, for the Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125-33. [Ref.ID 68660]
8.Tiene citas relacionadas Cita con resumen
Macaubas C, de Klerk NH, Holt BJ, Wee C, Kendall G, Firth M, Sly PD, Holt PG. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet 2003;362:1192-7. [Ref.ID 67811]
9.Tiene citas relacionadas Cita con resumen
Holberg CJ, Halonen M. Cytokines, atopy, and asthma. Lancet 2003;362:1166-667. [Ref.ID 67804]
10. Cita con resumen
Cinati J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet 2003;362:293-4. [Ref.ID 66960]
11. Cita con resumen
7Black G F, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Backwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PEM, Dockrell HM. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002;359:1393-401. [Ref.ID 61419]
12. Cita con resumen
Constantin A, Navaux F, Lawers-Cancès V, Abbal M, van Meerwijk JPM, Mazières B, Cambon-Thomsen A, Cantagrel A. Interferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2001;358:2051-2. [Ref.ID 60073]
13. Cita con resumen
Pokorny V, McLean L, McQueen F, Abu-Maree M, Yeoman S. Interferon-gamma microsatellite and rheumatoid arthritis. Lancet 2001;358:122-3. [Ref.ID 57735]
14. Cita con resumen
Anzueto A, Angel L. Update in pulmonary disease. Ann Intern Med 2000;133:360-6. [Ref.ID 52932]
15.Tiene citas relacionadas
Berger A. Th1 and Th2 responses: what are they?. BMJ 2000;321:424. [Ref.ID 52412]
16.
Nainggolan L. Immune therapies offer glimmer of hope in HIV. Scrip 2000;2564:22-3. [Ref.ID 52376]
17.
León Prieto F, Argüelles Grande C, Botello Gil A. Perspectivas inmunoterapéuticas de la tuberculosis: citocinas y "vacunas" de ADN. Rev Clin Esp 2000;200:318-22. [Ref.ID 51777]
18.
Delves PJ, Roitt I M. The immune systems - Second of two parts. N Engl J Med 2000;343:108-17. [Ref.ID 51763]
19.
Berek JS. Interferon plus chemotherapy for primary treatment of ovarian cancer. Lancet 2000;356:6-7. [Ref.ID 51668]
20. Cita con resumen
Scanga CB, Le Gros G. Development of an asthma vaccine: research into BCG. Drugs 2000;59:1217-21. [Ref.ID 51190]
Seleccionar todas
 
 1 a 20 de 32 siguiente >>